Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 71% · prior close shown (market closed)
ClearPoint Neuro, Inc. shows stable business momentum based on AlphaOS pipeline evidence.
Why it matters: Revenue +18% YoY in Q2 FY2026.
3 signals not yet derived from pipeline evidence
What it means for the thesis — synthesis, not a raw event feed.
Pipeline evidence · 22d ago
CLPT's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on CLPT.
Free accounts see more of this; Premium sees all of it.
Reported figures for ClearPoint Neuro, Inc. — research only, not investment advice.
Updated
What happened recently for ClearPoint Neuro, Inc. (CLPT) — events, not interpretation.
Research & analysis only — not investment advice.
AlphaOS industries
Investment snapshot
CLPT's AI investment thesis
Upgrade to Premium for CLPT's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Prior close
$15.31
Market cap
$467.02M
Profitable
No
Revenue $10.88M
Net income
$-11.34M
FY Sep 26, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for ClearPoint Neuro, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow ClearPoint Neuro, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.